Cite
MLA Citation
Graeme L. Fraser et al.. “A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause.” Menopause, vol. 27, no. 4, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100141225422.0x000020